KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

CUSIP: 48576UAA4

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Debt / NOTE 3.000%10/1
Market price (% of par)
75.26%
Total 13F principal
$161,228,700
Principal change
+$105,700
Total reported market value
$131,158,902
Number of holders
17
Value change
-$7,147,490
Number of buys
7
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 48576UAA4?
CUSIP 48576UAA4 identifies 48576UAA4 - KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q3 2021

As of 30 Sep 2021, KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 was held by 17 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $161,228,700 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Davidson Kempner Capital Management LP, LAZARD ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, Opti Capital Management, LP, CAPSTONE INVESTMENT ADVISORS, LLC, STEELHEAD PARTNERS LLC, CNH PARTNERS LLC, Verition Fund Management LLC, and JPMORGAN CHASE & CO. This page lists 17 institutional bondholders reporting positions for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.